Liu JG, Zhou NX, Xia HT, Li CG, Li YZ, Li CH. Expression of FXYD6 in pancreatic adenocarcinoma and its clinical significance.
Shijie Huaren Xiaohua Zazhi 2008;
16:540-543. [DOI:
10.11569/wcjd.v16.i5.540]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the expression of FXYD6 in pancreatic carcinoma and its clinical significance.
METHODS: Immunohistochemistry was used to detect the expression of FXYD6. The relation between the expression of FXYD6 and the clinical pathological factors was analyzed.
RESULTS: FXYD6 was expressed in 42 of 47 pancreatic carcinoma tissue samples. The positive expression rate of FXYD6 in 47 pancreatic cancer tissue samples was 89.34% (42/47). Compared to the expression of FXYD6 in normal pancreatic tissue samples, the expression of FXYD6 in pancreatic carcinoma tissue samples had a statistically significant difference (χ2 = 10.8631, P = 0.0125). According to the FXYD6 expression level, 47 patients were divided into high expression group and low expression group. There was no statistically significant difference in age, gender, tumor size and distant metastasis between the two groups, while there were statistical significances in tumor-differentiation degree(χ2 = 11.562, P = 0.0031), lymphatic metastasis (χ2 = 4.1947, P = 0.0406), TNM staging (χ2 = 9.5995, P = 0.0223). The expression level of FXYD6 protein was related to tumor size (r = 0.2991), differentiation degree (r = 0.6980), lymphatic metastasis (r = 0.4971) and distant metastasis (r = 0.4967).
CONCLUSION: FXYD6 protein plays an important role in the development and progression of pancreatic cancer.
Collapse